Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Eczema | 7% - 12.5% | x | x | |
Pruritus | 2% - 6% | x | x | |
Gastrointestinal disorder | 3% | x | ||
Fungal infection | 3% | x | ||
Stinging | 2% - 10% | x | x | |
Dry skin | 2% | x | x | |
Skin burning sensation | 2% | x | ||
Redness | 1% | x | ||
Infection | x | |||
Rash | x | |||
Folliculitis | x | x | ||
Hypertrichosis | x | |||
Miliaria | x | x | ||
Telangiectasia | x | |||
Erythema | x | |||
Application site reaction | x | |||
Skin atrophy | x | x | ||
Growth retardation | x | |||
Skin irritation | x | |||
Skin striae | x | x | ||
Allergic contact dermatitis | x | x | ||
Leukoderma | x | x | ||
Acneiform eruption | x | x | ||
Dermatitis perioral | x | x | ||
Secondary adrenocortical insufficiency | x | |||
Atrophy | x | |||
Rash maculo-papular | x | |||
Secondary infection | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||
---|---|---|---|---|
Dermatitis atopic | x | |||
Skin disorder | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |